TELMISARTAN 40mg. IP + METOPROLOL 25mg. IP

A single-pill combination of an angiotensin receptor blocker and cardioselective β blocker for the treatment of uncontrolled hypertension. Widens blood vessels to lower blood pressure, improves blood flow, and decreases the workload on the heart. Offers greater and more consistent systolic and diastolic BP lowering over the 24-hour period. (Asmar, 2012) An effective drug in reducing blood pressure and achieving the blood pressure target. (A Prem Kumar, 2021) Provides a full 24-hour BP coverage, particularly protecting against the BP rise characterizing early morning hours. (Guido Grassi, 2008) Displays large and sustained reductions of blood pressure in patients with hypertension. (Domenico Galzerano, 2010) Reducing cardiovascular events and mortality in patients with hypertension and coronary heart diseases. (Dimitris P Papadopoulos, 2009) A promising drug that diminishes cardiovascular risk in high-risk patients. (Philippe R Akhrass, 2011) A beneficial therapeutic choice in the management of patients with hypertension. (M Sharpe, 2001)